$JAGX News Article - Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
https://marketwirenews.com/news-releases/napo...38748.html